Screener
Acadia Pharmaceuticals ACAD Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfIntangibleAssets.
The source filing: Acadia Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 25, 2026, 7:00 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-072519
| Line item | Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 |
|---|---|---|---|
| Cost of product sales | 88,998 | 81,841 | 41,638 |
| Research and development | 328,802 | 303,249 | 351,619 |
| Selling, general and administrative | 548,894 | 488,428 | 406,559 |
| Gain on sale of non-financial asset | — | (146,515) | — |
| Total operating expenses | 966,694 | 727,003 | 799,816 |
| Income (loss) from operations | 104,811 | 230,794 | (73,379) |
| Interest income, net | 31,722 | 25,458 | 17,234 |
| Other income | 2,371 | 1,823 | 5,109 |
Item 16. Form 10-K Summary
FAQ
- What is Acadia Pharmaceuticals's gain (loss) on disposal of assets?
- Acadia Pharmaceuticals (ACAD) reported gain (loss) on disposal of assets of $0 in Q4 2025.
- How has Acadia Pharmaceuticals's gain (loss) on disposal of assets changed year-over-year?
- Acadia Pharmaceuticals's gain (loss) on disposal of assets decreased by 100.0% year-over-year, from $36.63M to $0.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.
Ask your AI about Acadia Pharmaceuticals's gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude